Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03128853 · ClinicalTrials.gov registry record · NA
Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT03128853 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 57 participants.
The verdict
NCT03128853, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
Single-arm study to investigate the repeatability and reproducibility of SpHb measurements from the Rad-67 and DCI Mini sensor.
Interventions
- DEVICE Rad-67 and DCI Mini Sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2016-10-31 |
| Est. Completion | 2016-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03128853
The ClinicalTrials.gov registry entry for NCT03128853 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rad-67 and DCI Mini Sensor is the first listed.
NCT03128853 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03128853 about?
NCT03128853 is a clinical study titled "Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility". Single-arm study to investigate the repeatability and reproducibility of SpHb measurements from the Rad-67 and DCI Mini sensor.
What is the current status of trial NCT03128853?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2016-10-31. Estimated completion is 2016-11-15.
What interventions are being tested in trial NCT03128853?
The interventions under investigation include: Rad-67 and DCI Mini Sensor (DEVICE).
Who is sponsoring clinical trial NCT03128853?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.